| Year |
Citation |
Score |
| 2020 |
Grubbs EG, Halperin DM, Waguespack SG, Gagel RF. History of the multiple endocrine neoplasia workshops and overview of MEN2019. Endocrine-Related Cancer. PMID 32508314 DOI: 10.1530/Erc-20-0201 |
0.339 |
|
| 2019 |
Sinha KM, Bagheri-Yarmand R, Lahiri S, Lu Y, Zhang M, Amra S, Rizvi Y, Wan X, Navone N, Ozpolat B, Logothetis C, Gagel RF, Huard J. Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer. Oncogene. PMID 30858546 DOI: 10.1038/S41388-019-0774-X |
0.312 |
|
| 2019 |
Bagheri-Yarmand R, Li L, Tarapore R, Allen JE, Sherman SI, Gagel RF. Abstract 1286: ONC201 inhibits RET and IGFBP2 signaling through ATF4 mediated- Integrated stress response in medullary thyroid cancer Cancer Research. 79: 1286-1286. DOI: 10.1158/1538-7445.Am2019-1286 |
0.346 |
|
| 2018 |
Bagheri-Yarmand R, Sinha KM, Li L, Lu Y, Cote GJ, Sherman SI, Gagel RF. Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress-Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer. Molecular Cancer Research : McR. PMID 30552230 DOI: 10.1158/1541-7786.Mcr-18-0354 |
0.316 |
|
| 2018 |
Romero Arenas MA, Rich TA, Hyde SM, Busaidy NL, Cote GJ, Hu MI, Gagel RF, Gidley PW, Jimenez C, Kupferman ME, Peterson SK, Sherman SI, Ying A, Bassett RL, Waguespack SG, et al. Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Annals of Surgical Oncology. PMID 29427212 DOI: 10.1245/S10434-018-6366-0 |
0.301 |
|
| 2018 |
Bagheri-Yarmand R, Sinha KM, Li L, Lu Y, Gagel RF. Abstract 2426: Tyrosine kinase and ERAD inhibitors promote oxidative stress-induced apoptosis through activation of ATF4 / KLF9 axis in medullary thyroid cancer Cancer Research. 78: 2426-2426. DOI: 10.1158/1538-7445.Am2018-2426 |
0.316 |
|
| 2017 |
Voss RK, Feng L, Lee JE, Perrier ND, Graham PH, Hyde SM, Nieves-Munoz F, Cabanillas ME, Waguespack SG, Cote GJ, Gagel RF, Grubbs EG. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate or High-Risk RET Mutations Do Not Predict Disease Aggressiveness The Journal of Clinical Endocrinology and Metabolism. PMID 28609830 DOI: 10.1210/Jc.2017-00317 |
0.32 |
|
| 2017 |
Bagheri-Yarmand R, Sinha K, Lu Y, Gagel R. Abstract LB-112: Tyrosine kinase and ERAD inhibitors synergize to promote apoptosis through ATF4 induction in medullary thyroid cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-112 |
0.336 |
|
| 2016 |
Bagheri-Yarmand R, Williams MD, Grubbs EG, Gagel RF. ATF4 Targets RET for Degradation and is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer. The Journal of Clinical Endocrinology and Metabolism. jc20162878. PMID 27935748 DOI: 10.1210/Jc.2016-2878 |
0.354 |
|
| 2016 |
Long KL, Etzel C, Rich T, Hyde S, Perrier ND, Graham PH, Lee JE, Hu MI, Cote GJ, Gagel R, Grubbs EG. All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients. Familial Cancer. PMID 27864651 DOI: 10.1007/S10689-016-9948-7 |
0.335 |
|
| 2016 |
Xu JY, Grubbs EG, Waguespack SG, Jimenez C, Gagel RF, Sosa JA, Vassilopoulou-Sellin R, Dadu R, Hu MI, Trotter CS, Jackson M, Rich TA, Hyde SM, Sherman SI, Cote GJ. Medullary Thyroid Carcinoma Associated with Germline RET K666N Mutation. Thyroid : Official Journal of the American Thyroid Association. PMID 27673361 DOI: 10.1089/Thy.2016.0374 |
0.353 |
|
| 2016 |
Xu JY, Murphy WA, Milton DR, Jimenez C, Rao SN, Habra MA, Waguespack SG, Dadu R, Gagel RF, Ying AK, Cabanillas ME, Weitzman SP, Busaidy NL, Sellin RV, Grubbs E, et al. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. The Journal of Clinical Endocrinology and Metabolism. jc20162815. PMID 27662441 DOI: 10.1210/Jc.2016-2815 |
0.358 |
|
| 2016 |
Grubbs EG, Williams MD, Scheet P, Vattathil S, Perrier N, Lee JE, Gagel RF, Hai T, Feng L, Cabanillas M, Cote GJ. The role of CDKN2C copy number in sporadic medullary thyroid carcinoma. Thyroid : Official Journal of the American Thyroid Association. PMID 27610696 DOI: 10.1089/Thy.2016.0224 |
0.372 |
|
| 2016 |
Bagheri-Yarmand R, Cote GJ, Grubbs EG, Williams MD, Sherman SI, Gagel RF. Abstract 3660: ATF4 is a putative tumor suppressor gene in medullary thyroid cancer Cancer Research. 76: 3660-3660. DOI: 10.1158/1538-7445.Am2016-3660 |
0.366 |
|
| 2015 |
Dadu R, Hu MN, Grubbs EG, Gagel RF. Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 204: 227-49. PMID 26494392 DOI: 10.1007/978-3-319-22542-5_11 |
0.338 |
|
| 2015 |
Grubbs EG, Gagel RF. My, How Things Have Changed in Multiple Endocrine Neoplasia Type 2A! The Journal of Clinical Endocrinology and Metabolism. 100: 2532-5. PMID 26151398 DOI: 10.1210/Jc.2015-2516 |
0.376 |
|
| 2015 |
Bagheri-Yarmand R, Sinha KM, Gururaj AE, Ahmed Z, Rizvi YQ, Huang SC, Ladbury JE, Bogler O, Williams MD, Cote GJ, Gagel RF. A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis. The Journal of Biological Chemistry. 290: 11749-61. PMID 25795775 DOI: 10.1074/Jbc.M114.619833 |
0.311 |
|
| 2015 |
Kwatampora L, Clarke C, Silva A, Zorba Y, Williams MD, Broaddus R, Clayman GL, El-Naggar AK, Gagel RF, Grubbs EG, Habra MA, Hu MI, Jimenez C, Kopetz S, Lee JE, et al. Recurrent parathyroid carcinoma and the need for molecular profiling to aid in prognostication and therapeutics. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E17012 |
0.338 |
|
| 2014 |
Rich TA, Feng L, Busaidy N, Cote GJ, Gagel RF, Hu M, Jimenez C, Lee JE, Perrier N, Sherman SI, Waguespack SG, Ying A, Grubbs E. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. Thyroid : Official Journal of the American Thyroid Association. 24: 1096-106. PMID 24617864 DOI: 10.1089/Thy.2013.0620 |
0.337 |
|
| 2014 |
Jain P, Baez-Vallecillo L, Huh YO, Benjamini O, Abruzzo L, O'Brien S, Pemmaraju N, Keating M, Gagel RF, Estrov Z. Atypical chronic lymphocytic leukemia with polyglandular autoimmune endocrinopathy type II: a complex profile. Leukemia & Lymphoma. 55: 944-6. PMID 23829280 DOI: 10.3109/10428194.2013.813666 |
0.332 |
|
| 2014 |
Bagheri-Yarmand R, Cote GJ, Gagel RF. Abstract 5262: Activating transcription factor 4 regulates RET autophosphorylation and ubiquitin-dependent degradation Cancer Research. 74: 5262-5262. DOI: 10.1158/1538-7445.Am2014-5262 |
0.338 |
|
| 2013 |
Thosani S, Ayala-Ramirez M, Palmer L, Hu MI, Rich T, Gagel RF, Cote G, Waguespack SG, Habra MA, Jimenez C. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. The Journal of Clinical Endocrinology and Metabolism. 98: E1813-9. PMID 24030942 DOI: 10.1210/Jc.2013-1653 |
0.321 |
|
| 2013 |
Carhill AA, Cabanillas ME, Jimenez C, Waguespack SG, Habra MA, Hu M, Ying A, Vassilopoulou-Sellin R, Gagel RF, Sherman SI, Busaidy NL. The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring. The Journal of Clinical Endocrinology and Metabolism. 98: 31-42. PMID 23185034 DOI: 10.1210/Jc.2012-2909 |
0.307 |
|
| 2011 |
Gagel RF. Activation of G-protein-coupled receptors and thyroid malignant tumors: the jury is still out. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 17: 957-9. PMID 22193147 DOI: 10.4158/Ep.17.6.957 |
0.319 |
|
| 2011 |
Hoff AO, Toth B, Hu M, Hortobagyi GN, Gagel RF. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients. Annals of the New York Academy of Sciences. 1218: 47-54. PMID 20946574 DOI: 10.1111/J.1749-6632.2010.05771.X |
0.315 |
|
| 2011 |
Cash K, Gagel R, Palmer JL, Thomas DA, Mattiuzzi G, Kantarjian HM, O'Brien S, Hu M, Jimenez C, Cabanillas ME. A Randomized, Double Blinded Study of Risedronate Versus Placebo for the Prevention of Bone Loss in Patients Receiving High Dose Corticosteroids for the Treatment of Acute Lymphocytic Leukemia and Lymphoblastic Lymphoma Blood. 118: 1486-1486. DOI: 10.1182/Blood.V118.21.1486.1486 |
0.302 |
|
| 2010 |
Ye L, Santarpia L, Gagel RF. The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors. Endocrine Reviews. 31: 578-99. PMID 20605972 DOI: 10.1210/Er.2009-0031 |
0.334 |
|
| 2010 |
Cabanillas ME, Kurzrock R, Sherman SI, Tsimberidou AM, Waguespack S, Naing A, Busaidy N, Gagel R, Wright JJ, Hong DS. Phase I trial of combination sorafenib and tipifarnib: The experience in advanced differentiated thyroid cancer (DTC) and medullary thyroid cancer (MTC). Journal of Clinical Oncology. 28: 5586-5586. DOI: 10.1200/Jco.2010.28.15_Suppl.5586 |
0.339 |
|
| 2009 |
Ye L, Santarpia L, Gagel RF. Targeted therapy for endocrine cancer: the medullary thyroid carcinoma paradigm. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 15: 597-604. PMID 19546050 DOI: 10.4158/Ep09148.Rar |
0.363 |
|
| 2009 |
Santarpia L, Gagel RF, Sherman SI, Sarlis NJ, Evans DB, Hoff AO. Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer. Head & Neck. 31: 419-23. PMID 18798312 DOI: 10.1002/Hed.20911 |
0.336 |
|
| 2009 |
Gagel RF. An overview of molecular abnormalities leading to thyroid carcinogenesis: A 1993 perspective Stem Cells. 15: 7-13. PMID 9368282 DOI: 10.1002/Stem.5530150705 |
0.366 |
|
| 2008 |
Ye L, Santarpia L, Cote GJ, El-Naggar AK, Gagel RF. High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 93: 4367-72. PMID 18765511 DOI: 10.1210/Jc.2008-0912 |
0.349 |
|
| 2008 |
Santarpia L, El-Naggar AK, Sherman SI, Hymes SR, Gagel RF, Shaw S, Sarlis NJ. Four patients with cutaneous metastases from medullary thyroid cancer. Thyroid : Official Journal of the American Thyroid Association. 18: 901-5. PMID 18651821 DOI: 10.1089/Thy.2007.0179 |
0.357 |
|
| 2008 |
Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, et al. Recent advances in thyroid cancer. Current Problems in Surgery. 45: 156-250. PMID 18346477 DOI: 10.1067/J.Cpsurg.2007.12.010 |
0.314 |
|
| 2007 |
Wells SA, Gosnell JE, Gagel RF, Moley JF, Pfister DG, Sosa JA, Skinner M, Krebs A, Hou J, Schlumberger M. Vandetanib in metastatic hereditary medullary thyroid cancer: Follow-up results of an open-label phase II trial Journal of Clinical Oncology. 25: 6018-6018. DOI: 10.1200/Jco.2007.25.18_Suppl.6018 |
0.358 |
|
| 2006 |
Kouvaraki MA, Shapiro SE, Cote GJ, Lee JE, Yao JC, Waguespack SG, Gagel RF, Evans DB, Perrier ND. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World Journal of Surgery. 30: 643-53. PMID 16680581 DOI: 10.1007/S00268-006-0360-Y |
0.302 |
|
| 2006 |
Tashjian AH, Gagel RF. Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 21: 354-65. PMID 16491282 DOI: 10.1359/Jbmr.051023 |
0.476 |
|
| 2006 |
Hoff AO, Toth BB, Altundag K, Guarneri V, Adamus A, Nooka AK, Sayegh GG, Johnson MM, Gagel RF, Hortobagyi GN. Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy Journal of Clinical Oncology. 24: 8528-8528. DOI: 10.1200/Jco.2006.24.18_Suppl.8528 |
0.319 |
|
| 2006 |
Hoff PM, Hoff AO, Phan AT, Sherman SI, Yao J, White N, Phan L, Abbruzzese JL, Gagel RF. Phase I/II trial of capecitabine (C), dacarbazine (D) and imatinib (I) (CDI) for patients (pts) metastatic medullary thyroid carcinomas (MTC) Journal of Clinical Oncology. 24: 13048-13048. DOI: 10.1200/Jco.2006.24.18_Suppl.13048 |
0.321 |
|
| 2005 |
Jimenez C, Yang Y, Kim HW, Al-Sagier F, Berry DA, El-Naggar AK, Patel S, Vassilopoulou-Sellin R, Gagel RF. Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 20: 1562-8. PMID 16059628 DOI: 10.1359/Jbmr.050507 |
0.31 |
|
| 2005 |
Sherman SI, Angelos P, Ball DW, Beenken SW, Byrd D, Clark OH, Daniels GH, Dilawari RA, Ehya H, Farrar WB, Gagel RF, Kandeel F, Kloos RT, Kopp P, Lamonica DM, et al. Thyroid carcinoma. Journal of the National Comprehensive Cancer Network : Jnccn. 3: 404-57. PMID 16002006 DOI: 10.6004/Jnccn.2005.0021 |
0.338 |
|
| 2004 |
Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. The Journal of Clinical Endocrinology and Metabolism. 89: 4142-5. PMID 15292360 DOI: 10.1210/Jc.2004-0041 |
0.334 |
|
| 2004 |
Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, et al. Parathyroid carcinoma: a 22-year experience. Head & Neck. 26: 716-26. PMID 15287039 DOI: 10.1002/Hed.20049 |
0.316 |
|
| 2004 |
Jimenez C, Dang GT, Schultz PN, El-Naggar A, Shapiro S, Barnes EA, Evans DB, Vassilopoulou-Sellin R, Gagel RF, Cote GJ, Hoff AO. A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 89: 3521-6. PMID 15240641 DOI: 10.1210/Jc.2004-0073 |
0.351 |
|
| 2004 |
Jimenez C, Gagel RF. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2). Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 14: S150-7. PMID 15135800 DOI: 10.1016/J.Ghir.2004.03.033 |
0.304 |
|
| 2003 |
Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB. Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. Surgery. 134: 890-9; discussion 89. PMID 14668720 DOI: 10.1016/S0039-6060(03)00408-2 |
0.373 |
|
| 2003 |
Shapiro SE, Cote GC, Lee JE, Gagel RF, Evans DB. The role of genetics in the surgical management of familial endocrinopathy syndromes. Journal of the American College of Surgeons. 197: 818-31. PMID 14585420 DOI: 10.1016/J.Jamcollsurg.2003.07.001 |
0.342 |
|
| 2003 |
Huang SC, Torres-Cruz J, Pack SD, Koch CA, Vortmeyer AO, Mannan P, Lubensky IA, Gagel RF, Zhuang Z. Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 88: 459-63. PMID 12519890 DOI: 10.1210/Jc.2002-021254 |
0.328 |
|
| 2001 |
Koch CA, Huang SC, Moley JF, Azumi N, Chrousos GP, Gagel RF, Zhuang Z, Pacak K, Vortmeyer AO. Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma Oncogene. 20: 7809-7811. PMID 11753660 DOI: 10.1038/Sj.Onc.1204991 |
0.308 |
|
| 2001 |
Lenert JT, Barnett CC, Kudelka AP, Sellin RV, Gagel RF, Prieto VG, Skibber JM, Ross MI, Pisters PWT, Curley SA, Evans DB, Lee JE. Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery. 130: 1060-1067. PMID 11742339 DOI: 10.1067/Msy.2001.118369 |
0.342 |
|
| 2000 |
Schultz PN, Ginsberg L, McCutcheon IE, Samaan N, Leavens M, Gagel RF. Quinagolide in the management of prolactinoma Pituitary. 3: 239-249. PMID 11788012 DOI: 10.1023/A:1012884214668 |
0.315 |
|
| 2000 |
Barnett C.C. J, Varma DG, El-Naggar AK, Dackiw APB, Porter GA, Pearson AS, Kudelka AP, Gagel RF, Evans DB, Lee JE, Thompson N, Monchik J, Dudley N, Hamberger B, Farndon J, et al. Limitations of size as a criterion in the evaluation of adrenal tumors Surgery. 128: 973-983. PMID 11114632 DOI: 10.1067/Msy.2000.110237 |
0.319 |
|
| 2000 |
Dackiw APB, Sussman JJ, Fritsche HA, Delpassand ES, Stanford P, Hoff A, Gagel RF, Evans DB, Lee JE. Relative Contributions of Technetium Tc 99m Sestamibi Scintigraphy, Intraoperative Gamma Probe Detection, and the Rapid Parathyroid Hormone Assay to the Surgical Management of Hyperparathyroidism Archives of Surgery. 135: 550-557. PMID 10807279 DOI: 10.1001/Archsurg.135.5.550 |
0.302 |
|
| 2000 |
McCutcheon IE, Pieper DR, Fuller GN, Benjamin RS, Friend KE, Gagel RF. Pituitary carcinoma containing gonadotropins: treatment by radical excision and cytotoxic chemotherapy: case report. Neurosurgery. 46: 1233-9; discussion 1. PMID 10807257 DOI: 10.1097/00006123-200005000-00042 |
0.325 |
|
| 2000 |
Barnett CC, Dackiw APB, Pearson AS, Varma DG, El‐Naggar AK, Gagel RF, Evans DB, Lee JE. Limitations of size as a criterion in evaluating adrenal tumours British Journal of Surgery. 87: 1270-1270. DOI: 10.1046/J.1365-2168.2000.01601-34.X |
0.309 |
|
| 1999 |
Fleming JB, Lee JE, Bouvet M, Schultz PN, Sherman SI, Sellin RV, Friend KE, Burgess MA, Cote GJ, Gagel RF, Evans DB. Surgical strategy for the treatment of medullary thyroid carcinoma Annals of Surgery. 230: 697-707. PMID 10561095 DOI: 10.1097/00000658-199911000-00013 |
0.338 |
|
| 1998 |
Lee JE, Evans DB, Hickey RC, Sherman SI, Gagel RF, Abbruzzese MC, Abbruzzese JL. Unknown primary cancer presenting as an adrenal mass: Frequency and implications for diagnostic evaluation of adrenal incidentalomas Surgery. 124: 1115-1122. PMID 9854592 DOI: 10.1067/Msy.1998.92009 |
0.342 |
|
| 1998 |
Yeung SCJ, Eton O, Burton DW, Deftos LJ, Vassilopoulou-Sellin R, Gagel RF. Hypercalcemia Due To Parathyroid Hormone-Related Protein Secretion By Melanoma Hormone Research in Paediatrics. 49: 288-291. PMID 9623520 DOI: 10.1159/000023188 |
0.338 |
|
| 1996 |
Lee JE, Curley SA, Gagel RF, Evans DB, Hickey RC, Pasieka JL, Hamberger B, Thompson NW, Danto LA. Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma Surgery. 120: 1064-1071. PMID 8957496 DOI: 10.1016/S0039-6060(96)80056-0 |
0.326 |
|
| 1996 |
Gagel RF, Goepfert H, Callender DL. Changing concepts in the pathogenesis and management of thyroid carcinoma Ca-a Cancer Journal For Clinicians. 46: 261-283. PMID 8806393 DOI: 10.3322/Canjclin.46.5.261 |
0.343 |
|
| 1995 |
Cooley LD, Elder FFB, Knuth A, Gagel RF. Cytogenetic characterization of three human and three rat medullary thyroid carcinoma cell lines Cancer Genetics and Cytogenetics. 80: 138-149. PMID 7736432 DOI: 10.1016/0165-4608(94)00185-E |
0.334 |
|
| 1995 |
Garrett JE, Tamir H, Kifor O, Simin RT, Rogers KV, Mithal A, Gagel RF, Brown EM. Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology. 136: 5202-11. PMID 7588259 DOI: 10.1210/Endo.136.11.7588259 |
0.322 |
|
| 1995 |
Cote GJ, Wohllk N, Evans D, Goepfert H, Gagel RF. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Bailliere's Clinical Endocrinology and Metabolism. 9: 609-30. PMID 7575334 DOI: 10.1016/S0950-351X(95)80638-5 |
0.332 |
|
| 1995 |
Lee JE, Berger DH, El-Naggar AK, Hickey RC, Vassilopoulou-Sellin R, Gagel RF, Burgess MA, Evans DB. Surgical management, DNA content, and patient survival in adrenal cortical carcinoma Surgery. 118: 1090-1098. PMID 7491528 DOI: 10.1016/S0039-6060(05)80119-9 |
0.313 |
|
| 1995 |
Monla YT, Peleg S, Gagel RF, Monia YT. Cell type-specific regulation of transcription by cyclic adenosine 3,'5'-monophosphate-responsive elements within the calcitonin promoter. Molecular Endocrinology. 9: 784-793. PMID 7476962 DOI: 10.1210/Mend.9.7.7476962 |
0.308 |
|
| 1993 |
Gagel RF, Robinson MF, Donovan DT, Alford BR. Clinical review 44: Medullary thyroid carcinoma: recent progress. The Journal of Clinical Endocrinology and Metabolism. 76: 809-814. PMID 8473386 DOI: 10.1210/Jcem.76.4.8473386 |
0.346 |
|
| 1993 |
Evans DB, Skibber JM, Lee JE, Cleary KR, Ajani JA, Gagel RF, Sellin RV, Fenoglio CJ, Merrell RC, Hickey RC. Nonfunctioning islet cell carcinoma of the pancreas Surgery. 114: 1175-1182. DOI: 10.5555/Uri:Pii:003960609390341A |
0.336 |
|
| 1991 |
Peleg S, Abruzzese RV, Cote GJ, Gagel RF. Transcription of the human calcitonin gene is mediated by a C cell-specific enhancer containing E-box-like elements. Molecular Endocrinology (Baltimore, Md.). 4: 1750-7. PMID 2280775 DOI: 10.1210/Mend-4-11-1750 |
0.3 |
|
| 1990 |
Grauer A, Raue F, Gagel RF. Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma Endocrinology and Metabolism Clinics of North America. 19: 613-635. DOI: 10.1016/S0889-8529(18)30313-X |
0.357 |
|
| 1988 |
Gagel RF, Tashjian AH, Cummings T, Papathanasopoulos N, Kaplan MM, DeLellis RA, Wolfe HJ, Reichlin S. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. The New England Journal of Medicine. 318: 478-84. PMID 2893259 DOI: 10.1056/Nejm198802253180804 |
0.573 |
|
| 1988 |
Mallette LE, Kirkland JL, Gagel RF, Law WM, Heath H. Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 67: 964-972. PMID 2846629 DOI: 10.1210/Jcem-67-5-964 |
0.303 |
|
| 1986 |
Gagel RF, Palmer WN, Leonhart K, Chan L, Leong SS. Somatostatin production by a human medullary thyroid carcinoma cell line. Endocrinology. 118: 1643-51. PMID 2868883 DOI: 10.1210/Endo-118-4-1643 |
0.331 |
|
| 1983 |
ZeytinoÄŸlu FN, Gagel RF, Tashjian AH, Hammer RA, Leeman SE. Regulation of neurotensin release by a continuous line of mammalian C-cells: the role of biogenic amines. Endocrinology. 112: 1240-6. PMID 6832044 DOI: 10.1210/Endo-112-4-1240 |
0.515 |
|
| 1983 |
Gagel RF, O'Briain DS, Voelkel EF, Wolfe HJ, DeLellis RA, Lee AK, Tashjian AH. Pituitary immunoreactive calcitonin-like material: lack of evidence for cross-reactivity with pro-opiomelanocortin. Metabolism: Clinical and Experimental. 32: 686-96. PMID 6191178 DOI: 10.1016/0026-0495(83)90125-7 |
0.467 |
|
| 1982 |
Gagel RF, Jackson CE, Block MA, Feldman ZT, Reichlin S, Hamilton BP, Tashjian AH. Age-related probability of development of hereditary medullary thyroid carcinoma. The Journal of Pediatrics. 101: 941-6. PMID 7143171 DOI: 10.1016/S0022-3476(82)80014-0 |
0.544 |
|
| 1980 |
Spiler IJ, Kapcala LP, Graze K, Gagel RF, Feldman ZT, Biller B, Tashjian AH, Reichlin S. Effects of L-dopa and bromocriptine on calcitonin secretion in medullary thyroid carcinoma Journal of Clinical Endocrinology and Metabolism. 51: 806-809. PMID 7419666 DOI: 10.1210/Jcem-51-4-806 |
0.546 |
|
| 1980 |
Gagel RF, Zeytinoğlu FN, Voelkel EF, Tashjian AH. Establishment of a calcitonin-producing rat medullary thyroid carcinoma cell line. II. Secretory studies of the tumor and cells in culture. Endocrinology. 107: 516-23. PMID 7389665 DOI: 10.1210/Endo-107-2-516 |
0.53 |
|
| 1980 |
ZeytinoÄŸlu FN, Gagel RF, Tashjian AH, Hammer RA, Leeman SE. Characterization of neurotensin production by a line of rat medullary thyroid carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America. 77: 3741-5. PMID 6932046 DOI: 10.1073/Pnas.77.6.3741 |
0.535 |
|
| 1980 |
Zeytinoğlu FN, DeLellis RA, Gagel RF, Wolfe HJ, Tashjian AH. Establishment of a calcitonin-producing rat medullary thyroid carcinoma cell line. I. Morphological studies of the tumor and cells in culture. Endocrinology. 107: 509-15. PMID 6248326 DOI: 10.1210/endo-107-2-509 |
0.501 |
|
| 1978 |
Graze K, Spiler IJ, Tashjian AH, Melvin KE, Cervi-Skinner S, Gagel RF, Miller HH, Wolfe HJ, DeLellis RA, Leape L, Feldman ZT, Reichlin S. Natural history of familial medullary thyroid carcinoma. Effect of a program for early diagnosis New England Journal of Medicine. 299: 980-985. PMID 692625 DOI: 10.1056/Nejm197811022991804 |
0.581 |
|
| 1977 |
Rocklin RE, Gagel R, Feldman Z, Tashjian AH. Cellular immune responses in familial medullary thyroid carcinoma New England Journal of Medicine. 296: 835-838. PMID 321956 DOI: 10.1056/Nejm197704142961502 |
0.569 |
|
| 1976 |
Leape LL, Miller HH, Graze K, Feldman ZT, Gagel RF, Wolfe HJ, Delellis RA, Tashjian AH, Reichlin S. Total thyroidectomy for occult familial medullary carcinoma of the thyroid in children Journal of Pediatric Surgery. 11: 831-837. PMID 993955 DOI: 10.1016/0022-3468(76)90111-1 |
0.511 |
|
| Show low-probability matches. |